{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:21:10Z","timestamp":1723422070210},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,11]]},"DOI":"10.7759\/cureus.66639","type":"journal-article","created":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T15:09:16Z","timestamp":1723388956000},"source":"Crossref","is-referenced-by-count":0,"title":["The Interplay of Chronic Hepatitis C and COVID-19: Implications for Prognosis and Treatment"],"prefix":"10.7759","author":[{"given":"Stefan D","family":"Lazar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreea F","family":"Stoenescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corneliu Petru","family":"Popescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simin","family":"Florescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geta","family":"Vancea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petre","family":"Calistru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2020.09.018","article-title":"The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2","volume":"179","author":"Muralidar S","year":"2020","unstructured":"Muralidar S, Ambi SV, Sekaran S, Krishnan UM. The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2. Biochimie. 2020, 179:85-100. 10.1016\/j.biochi.2020.09.018","journal-title":"Biochimie"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-05897-z","article-title":"Clinical characteristics of coronavirus disease 2019 (COVID-19) in patients out of Wuhan from China: a case control study","volume":"21","author":"Zhang H","year":"2021","unstructured":"Zhang H, Du F, Cao XJ, et al.. Clinical characteristics of coronavirus disease 2019 (COVID-19) in patients out of Wuhan from China: a case control study. BMC Infect Dis. 2021, 21:207. 10.1186\/s12879-021-05897-z","journal-title":"BMC Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2010419","article-title":"Clinical characteristics of Covid-19 in New York City","volume":"382","author":"Goyal P","year":"2020","unstructured":"Goyal P, Choi JJ, Pinheiro LC, et al.. Clinical characteristics of Covid-19 in New York City. N Engl J Med. 2020, 382:2372-4. 10.1056\/NEJMc2010419","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.15537\/smj.2022.43.9.20220343","article-title":"Clinical characteristics and outcomes among patients with COVID-19: A single-center retrospective observational study from Marj, Libya","volume":"43","author":"Khalifa AM","year":"2022","unstructured":"Khalifa AM, Nouh FA, Elshaari FA. Clinical characteristics and outcomes among patients with COVID-19: A single-center retrospective observational study from Marj, Libya. Saudi Med J. 2022, 43:1013-9. 10.15537\/smj.2022.43.9.20220343","journal-title":"Saudi Med J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-023-16143-3","article-title":"Substantial impact of the COVID-19 pandemic on the reported number of diagnosed chronic hepatitis C virus infections in the Netherlands, 2019-2021","volume":"23","author":"den Boogert EM","year":"2023","unstructured":"den Boogert EM, Veldhuijzen IK, Generaal E, et al.. Substantial impact of the COVID-19 pandemic on the reported number of diagnosed chronic hepatitis C virus infections in the Netherlands, 2019-2021. BMC Public Health. 2023, 23:1244. 10.1186\/s12889-023-16143-3","journal-title":"BMC Public Health"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60242-0","article-title":"The cryoglobulinaemias","volume":"28","author":"Ramos-Casals M","year":"2012","unstructured":"Ramos-Casals M, Stone JH, Cid MC, Bosch X. The cryoglobulinaemias. Lancet. 2012, 28:348-60. 10.1016\/S0140-6736(11)60242-0","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/v13112249","article-title":"A review on extrahepatic manifestations of chronic hepatitis C virus infection and the impact of direct-acting antiviral therapy","volume":"13","author":"Mazzaro C","year":"2021","unstructured":"Mazzaro C, Quartuccio L, Adinolfi LE, et al.. A review on extrahepatic manifestations of chronic hepatitis C virus infection and the impact of direct-acting antiviral therapy. Viruses. 2021, 13:10.3390\/v13112249","journal-title":"Viruses"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2015.07.008","article-title":"Hepatitis C virus: a European perspective","volume":"44","author":"Dultz G","year":"2015","unstructured":"Dultz G, Zeuzem S. Hepatitis C virus: a European perspective. Gastroenterol Clin North Am. 2015, 44:807-24. 10.1016\/j.gtc.2015.07.008","journal-title":"Gastroenterol Clin North Am"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/20503121221105957","article-title":"Epidemiology, risk factors, and pathogenesis associated with a superbug: A comprehensive literature review on hepatitis C virus infection","volume":"10","author":"Tariq M","year":"2022","unstructured":"Tariq M, Shoukat AB, Akbar S, et al.. Epidemiology, risk factors, and pathogenesis associated with a superbug: A comprehensive literature review on hepatitis C virus infection. SAGE Open Med. 2022, 10:20503121221105957. 10.1177\/20503121221105957","journal-title":"SAGE Open Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.721793","article-title":"Risk factors for severe COVID-19 and hepatitis C infections: the dual role of ppolipoprotein E4","volume":"13","author":"Lima FB","year":"2022","unstructured":"Lima FB, Bezerra KC, Nascimento JC, Meneses GC, Ori\u00e1 RB. Risk factors for severe COVID-19 and hepatitis C infections: the dual role of ppolipoprotein E4. Front Immunol. 2022, 13:721793. 10.3389\/fimmu.2022.721793","journal-title":"Front Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v9.i29.8749","article-title":"Chronic hepatitis-C infection in COVID-19 patients is associated with in-hospital mortality","volume":"9","author":"Ronderos D","year":"2021","unstructured":"Ronderos D, Omar AM, Abbas H, et al.. Chronic hepatitis-C infection in COVID-19 patients is associated with in-hospital mortality. World J Clin Cases. 2021, 9:8749-62. 10.12998\/wjcc.v9.i29.8749","journal-title":"World J Clin Cases"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57060597","article-title":"Liver impairment and hematological changes in patients with chronic hepatitis C and COVID-19: a retrospective study after one year of pandemic","volume":"57","author":"Cerbu B","year":"2021","unstructured":"Cerbu B, Pantea S, Bratosin F, et al.. Liver impairment and hematological changes in patients with chronic hepatitis C and COVID-19: a retrospective study after one year of pandemic. Medicina (Kaunas). 2021, 57:10.3390\/medicina57060597","journal-title":"Medicina (Kaunas)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-022-08921-5","article-title":"Risk and protective factors for COVID-19 morbidity, severity, and mortality","volume":"64","author":"Zhang JJ","year":"2023","unstructured":"Zhang JJ, Dong X, Liu GH, Gao YD. Risk and protective factors for COVID-19 morbidity, severity, and mortality. Clin Rev Allergy Immunol. 2023, 64:90-107. 10.1007\/s12016-022-08921-5","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.21315\/mjms2023.30.3.7","article-title":"Risk factors associated with the severity of COVID-19","volume":"30","author":"Martono","year":"2023","unstructured":"Martono, Fatmawati F, Mulyanti S. Risk factors associated with the severity of COVID-19. Malays J Med Sci. 2023, 30:84-92. 10.21315\/mjms2023.30.3.7","journal-title":"Malays J Med Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-020-01509-1","article-title":"Risk factors for Covid-19 severity and fatality: a structured literature review","volume":"49","author":"Wolff D","year":"2021","unstructured":"Wolff D, Nee S, Hickey NS, Marschollek M. Risk factors for Covid-19 severity and fatality: a structured literature review. Infection. 2021, 49:15-28. 10.1007\/s15010-020-01509-1","journal-title":"Infection"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14455","article-title":"Liver impairment in COVID-19 patients: a retrospective analysis of 115 cases from a single centre in Wuhan city, China","volume":"40","author":"Zhang Y","year":"2020","unstructured":"Zhang Y, Zheng L, Liu L, Zhao M, Xiao J, Zhao Q. Liver impairment in COVID-19 patients: a retrospective analysis of 115 cases from a single centre in Wuhan city, China. Liver Int. 2020, 40:2095-103. 10.1111\/liv.14455","journal-title":"Liver Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i42.7362","article-title":"Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study","volume":"27","author":"Afify S","year":"2021","unstructured":"Afify S, Eysa B, Hamid FA, et al.. Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study. World J Gastroenterol. 2021, 27:7362-75. 10.3748\/wjg.v27.i42.7362","journal-title":"World J Gastroenterol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0243700","article-title":"Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: findings from COVOCA study","volume":"15","author":"Galiero R","year":"2020","unstructured":"Galiero R, Pafundi PC, Simeon V, et al.. Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: findings from COVOCA study. PLoS One. 2020, 15:e0243700. 10.1371\/journal.pone.0243700","journal-title":"PLoS One"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/279649-the-interplay-of-chronic-hepatitis-c-and-covid-19-implications-for-prognosis-and-treatment","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T15:09:18Z","timestamp":1723388958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/279649-the-interplay-of-chronic-hepatitis-c-and-covid-19-implications-for-prognosis-and-treatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,11]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.66639","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,11]]}}}